BIOREGULATOR / DIRECT CATALOG PRICING
Chonluten (T-34)
Chonluten is a Russian bioregulator trade name described in one primary paper as a tripeptide derived from bronchial epithelial cells; the abstract does not disclose enough chemistry to verify the exact sequence of this catalog item.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Bioregulator
Choose a listed format
- 20 mgRequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Chonluten is a Russian bioregulator trade name described in one primary paper as a tripeptide derived from bronchial epithelial cells; the abstract does not disclose enough chemistry to verify the exact sequence of this catalog item.
The bioregulator classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Bioregulator
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Chonluten is a Russian bioregulator trade name described in one primary paper as a tripeptide derived from bronchial epithelial cells; the abstract does not disclose enough chemistry to verify the exact sequence of this catalog item.
- Research covered
- Chonluten was tested in vitro in the human THP-1 monocytic leukemia cell line, including differentiated macrophage conditions, with measurements of proliferation-related signaling and inflammatory markers.
- Important limit
- This is a cell-line study, not human clinical evidence. The exact sequence and composition of the catalog material cannot be independently verified from the trade name or the cited abstract.
- Authoritative sources
FACTUAL FAQ
Chonluten (T-34) catalog questions
What formats are currently listed?
20 mg. Current price and stock state appear above.
What did researchers study?
Chonluten was tested in vitro in the human THP-1 monocytic leukemia cell line, including differentiated macrophage conditions, with measurements of proliferation-related signaling and inflammatory markers.
What is the most important evidence limit?
This is a cell-line study, not human clinical evidence. The exact sequence and composition of the catalog material cannot be independently verified from the trade name or the cited abstract.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →